Acutaas Chemicals Limited has reached a significant milestone in its sustainability journey, securing a Platinum Medal accreditation from EcoVadis, a renowned global provider of business sustainability ratings. This achievement, announced on August 26, 2025, places Acutaas Chemicals among the top 1% of companies assessed by EcoVadis worldwide for sustainability performance.

Sustainability Upgrade

The Platinum Medal represents a notable upgrade from Acutaas Chemicals' previous Gold Medal rating, reflecting the company's continued commitment to environmental, social, and governance (ESG) practices. This improvement demonstrates Acutaas Chemicals' dedication to enhancing its sustainability efforts across various aspects of its operations.

EcoVadis Assessment

EcoVadis evaluates companies based on a comprehensive set of sustainability criteria, including:

• Environmental practices
• Labor and human rights
• Ethics
• Sustainable procurement

The Platinum Medal is the highest recognition offered by EcoVadis, reserved for companies that demonstrate exceptional performance in these areas.

Company's Response

In an official statement to the stock exchanges on August 27, 2025, Acutaas Chemicals Limited expressed pride in this achievement. Ekta Kumari Srivastava, Company Secretary & Compliance Officer, stated:

"The EcoVadis Platinum Rating is the Sustainability scorecard which has put the Company amongst top 1% of the companies assessed by EcoVadis globally."

Industry Impact

As a chemical company, Acutaas Chemicals' achievement is particularly noteworthy. The chemical sector often faces scrutiny regarding environmental impact and sustainability practices. This Platinum Medal accreditation may potentially enhance Acutaas Chemicals' reputation in the industry and among environmentally conscious investors and customers.

Looking Ahead

While this recognition is a significant accomplishment, it also sets a high bar for Acutaas Chemicals to maintain and potentially improve upon in the future. Stakeholders will likely be watching closely to see how the company leverages this achievement to drive further sustainability initiatives and maintain its position among the global leaders in corporate sustainability.

The Platinum Medal from EcoVadis not only recognizes Acutaas Chemicals' current sustainability efforts but also encourages continued focus on ESG factors, which are increasingly important in today's business landscape.

Acutaas Chemicals Limited , a leading manufacturer of advanced pharmaceutical intermediates and specialty chemicals, has announced robust financial results for the first quarter, ended June 30.

Financial Highlights

• Revenue from operations increased by 17.3% year-on-year to ₹2,072.00 crore
• EBITDA margin expanded significantly by 785 basis points to 24.6%
• Net profit surged by 199.6% to ₹440.00 crore
• Earnings per share (EPS) rose to ₹5.41, compared to ₹1.83 in the same quarter of the previous year

Strong Performance Across Segments

The company's growth was primarily driven by a strong performance in its Pharmaceutical Intermediates business. Acutaas Chemicals maintained a healthy export-to-domestic ratio, with exports accounting for 60% of the quarter's revenue and domestic sales contributing 40%.

Operational Achievements

Nareshkumar R. Patel, Executive Chairman & Managing Director of Acutaas Chemicals Limited, commented on the results: "I am happy to share that we've had a strong start to the fiscal year, with Q1 revenue growing 17.3% year-on-year, driven by robust performance in our Pharmaceutical Intermediates business. Both our pharma facilities are now PMDA GMP certified, underscoring our commitment to global compliance and quality."

Strategic Expansion

Mr. Patel also announced a significant strategic move: "We have entered into a joint venture in South Korea which brings us closer to key semiconductor markets and strengthens our portfolio with differentiated, high-value products tailored for this space."

The company's wholly-owned subsidiary, Acutaas Advance Material Limited (AAML), has entered into a joint venture agreement with J & Materials Co. Ltd., a South Korean company. AAML will hold 75% of the share capital in the joint venture company, Indichem Inc., while J & Materials Co. Ltd. will hold the remaining 25%.

Investment in Subsidiary

Acutaas Chemicals has also made a significant investment in its wholly-owned subsidiary, AAML. The company has subscribed to 30,48,780 equity shares of AAML at ₹10 each, with a premium of ₹154 per share, through a rights issue. This investment, not exceeding ₹49.99 crore, is part of a larger commitment to invest up to ₹150.00 crore in AAML through a mix of loans and equity subscriptions.

Utilization of Preferential Issue Proceeds

The company reported complete utilization of the ₹99.10 crore raised through a preferential issue of equity shares allotted on May 31. The funds were allocated as originally planned:

Future Outlook

Mr. Patel expressed confidence in the company's future prospects, stating, "With rising customer engagement across CDMO, battery chemicals, and semiconductors, we step into the fiscal year with strong momentum and confidence to deliver 25% growth with improved margins."

Acutaas Chemicals Limited's strong start to the fiscal year, strategic expansions, and investments in high-growth areas position the company well for continued success in the specialty chemicals sector.